Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety.

Marzal-Alfaro MB, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, et al. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety. Health Informatics J. 2020;26(3):1995-2010. doi:10.1177/1460458219895434.

Save
Print
February 26, 2020
Marzal-Alfaro MB, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, et al. Health Informatics J. 2020;26(3):1995-2010.
View more articles from the same authors.

This study applied failure mode, effect, and criticality analysis (FMECA) methodology to identify the impact of an image-based workflow software on reducing chemotherapy errors. After software implementation, the overall medication error rate decreased significantly, as did all types of errors except wrong medicinal product errors.

Save
Print
Cite
Citation

Marzal-Alfaro MB, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, et al. Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients’ safety. Health Informatics J. 2020;26(3):1995-2010. doi:10.1177/1460458219895434.

Related Resources From the Same Author(s)
Related Resources